Transgene is a fully integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Our expertise covers all stages of product development, from research to the manufacture of clinical batches, and the conducting of clinical trials.

Four products are currently in clinical development: TG4010, JX594/TG6006, TG4001 and TG4040 in phase II trials.

Transgene has concluded strategic agreements with two pharmaceutical companies... >>> READ MORE

>>> Transgene in 10 questions	>>> Annual Report 2010	>>> R&D Day Webcast 2011	>>> 2011 Interim Financial Report